CPAP impact on memory processes in OSA patients, a randomized sham controlled trial

Marie Joyeux-Faure (Grenoble, France), Jean-Louis Pepin, Marie Joyeux-Faure, Bernadette Naegele, Renaud Tamisier, Patrick Levy, Sandrine Launois

Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Session: Treatment options for obstructive sleep apnoea and obesity hypoventilation
Session type: Poster Discussion
Number: 3422
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Abstract

Introduction. Patients with obstructive sleep apnea (OSA) exhibit cognitive dysfunctions such as significant memory impairment affecting the 3 episodic, procedural, and working memory systems. The objective of this study was to investigate the change in memory processes after continuous positive airway pressure (CPAP) treatment in OSA patients.Design and methods. In this randomized, double blinded, parallel groups and sham-controlled trial, 36 patients with OSA (AHI > 15/h) and naive of CPAP treatment were randomized to receive either CPAP (n=18) or sham-CPAP (n=18) for 6-week. Three separate memory systems (verbal episodic, procedural and working memories) were evaluated for all patients, before and after treatment.Results. Key demographics for the study population were: age 55 ± 11 years, 72.2% male, BMI: 29.5 ± 4.1 kg/m2, AHI: 37.1 ± 16.3 /h. Prior to treatment, memory performances of OSA patients were altered. In intention to treat analysis, mnesic deficit were not different after 6 weeks of CPAP or sham CPAP treatment: verbal episodic, procedural and working memory scores were comparable between both groups.Conclusions. While 6 weeks of CPAP was an effective treatment for OSA in terms of reducing breathing disruption during sleep, it did not improve memory processes of OSA patientsin terms of verbal episodic memory, visual-motor and reading procedural memory, auditory and spatialworking memory, which are known to be altered in this context. These results suggest that OSA-neurocognitive relationship is complex and further investigations with longer CPAP exposures (at least 2 months) or on selective population (such as severe OSA patients) would be of interest.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Marie Joyeux-Faure (Grenoble, France), Jean-Louis Pepin, Marie Joyeux-Faure, Bernadette Naegele, Renaud Tamisier, Patrick Levy, Sandrine Launois. CPAP impact on memory processes in OSA patients, a randomized sham controlled trial. Eur Respir J 2016; 48: Suppl. 60, 3422

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effects of suboptimal adherence of CPAP therapy on symptoms of obstructive sleep apnoea: a randomised, double-blind, controlled trial
Source: Eur Respir J, 55 (3) 1901526; 10.1183/13993003.01526-2019
Year: 2020



The role of CPAP treatment in elderly patients with moderate obstructive sleep apnoea: a multicentre randomised controlled trial
Source: Eur Respir J, 54 (2) 1900518; 10.1183/13993003.00518-2019
Year: 2019



Randomised controlled trial of the effect of CPAP in uncontrolled nocturnal asthmatic patients with OSAS.
Source: International Congress 2017 – CPAP therapy
Year: 2017


A prospective, randomised, controlled trial of CPAP in adults with Down syndrome
Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity
Year: 2015


Impact of a multimodal telemonitoring intervention on CPAP adherence in symptomatic low-cardiovascular risk sleep apnea: a randomized controlled trial
Source: Virtual Congress 2020 – The impact of different treatment modalities on obstructive sleep apnoea
Year: 2020




Effects of CPAP treatment on sex hormone levels in patients with obstructive sleep apnoea - data from two randomized, controlled trials
Source: International Congress 2019 – Current perspectives in obstructive sleep apnoea therapeutic plans and their effects
Year: 2019




OSAS treatment with CPAP: Randomized crossover study comparing tolerance and efficacy with and without humidification
Source: International Congress 2016 – Technical aspects, compliance, and adherence to positive airway pressure in sleep apnoea
Year: 2016


Cognitive behavioural therapy for insomnia reduces sleep apnoea severity: a randomised controlled trial
Source: ERJ Open Res, 6 (2) 00161-2020; 10.1183/23120541.00161-2020
Year: 2020



CPAP effects on leptin and visceral fat in patients with sleep apnea: Double-blind, randomized, controlled trial
Source: Annual Congress 2011 - Physiology and cardiometabolic comorbidities in obstructive sleep apnoea
Year: 2011

Randomized placebo-controlled trial: effects of continuous positive airway pressure in patients with hypertension ²non dipper² without treatment and obstructive sleep apnea
Source: Eur Respir J 2005; 26: Suppl. 49, 723s
Year: 2005

Telemetrically triggered interventions in the first month of cpap treatment - A prospective, randomized controlled intervention trial in patients with a new diagnosis of obstructive sleep apnea syndrome
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016


Impaired control of gait in severe obstructive sleep apnea and continuous positive airway pressure treatment: a randomized controlled trial
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019


The effects of short-term CPAP withdrawal on myocardial perfusion in OSA – A randomised placebo-controlled trial
Source: International Congress 2014 – Real or not? The impact of OSA and CPAP on comorbid conditions
Year: 2014

Continuous positive airway pressure effect on visual acuity in patients with type 2 diabetes and obstructive sleep apnoea: a multicentre randomised controlled trial
Source: Eur Respir J, 52 (4) 1801177; 10.1183/13993003.01177-2018
Year: 2018



AVAPS-AE vs. ST mode: A randomised controlled trial in patients with obesity hypoventilation syndrome
Source: International Congress 2018 – New insights in the management of chronic respiratory failure
Year: 2018



A randomized controlled trial of auto-titrating continuous positive airway pressure treatment for obstructive sleep apnoea after acute quadriplegia (COSAQ)
Source: International Congress 2016 – Epidemiological aspects of obstructive sleep apnoea
Year: 2016

CPAP therapy impact in OSA related symptoms – a prospective study
Source: Eur Respir J 2006; 28: Suppl. 50, 411s
Year: 2006

Mandibular advancement device versus continuous positive airway pressure for treatment of obstruvtive sleep apnea syndrome: a randomized crossover trial
Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Year: 2007


Long-term efficacy of motivational interviewing on improving continuous positive airway pressure adherence in obstructive sleep apnea: A randomized controlled trial
Source: Annual Congress 2013 –Twist in the tale: treating sleep disordered breathing - new technologies, new techniques
Year: 2013


OSA results in nocturnal cerebral hypoxia which is prevented by CPAP - Data from a randomised controlled trial
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015